Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · Real-Time Price · USD
0.315
+0.006 (1.97%)
Nov 21, 2024, 1:19 PM EST - Market open
Marinus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 17 | 593 | 197 | 437 | 434 | 178 | |
Market Cap Growth | -77.83% | 200.39% | -54.79% | 0.58% | 144.36% | 17.88% | |
Enterprise Value | 71 | 526 | 106 | 339 | 355 | 141 | |
Last Close Price | 0.31 | 10.87 | 3.98 | 11.88 | 12.20 | 8.64 | |
PS Ratio | 0.56 | 19.14 | 7.75 | 28.46 | 252.76 | - | |
PB Ratio | -1.45 | 35.38 | 1.70 | 8.17 | 3.17 | 2.02 | |
P/TBV Ratio | - | 35.38 | 1.76 | 8.88 | 3.27 | 2.98 | |
EV/Sales Ratio | 2.25 | 16.96 | 4.17 | 22.11 | 206.52 | - | |
Debt / Equity Ratio | -1.16 | 6.58 | 0.90 | 0.81 | 0.02 | 0.04 | |
Asset Turnover | 0.24 | 0.14 | 0.13 | 0.11 | 0.01 | - | |
Inventory Turnover | - | 81.38 | - | - | - | - | |
Quick Ratio | 1.22 | 3.79 | 9.87 | 3.11 | 13.20 | 11.42 | |
Current Ratio | 1.22 | 4.07 | 10.09 | 3.25 | 13.63 | 11.72 | |
Return on Equity (ROE) | - | -213.02% | -23.38% | -103.60% | -59.99% | -69.34% | |
Return on Assets (ROA) | -57.97% | -38.18% | -35.57% | -42.17% | -34.06% | -39.08% | |
Return on Capital (ROIC) | -87.94% | -47.37% | -44.52% | -51.11% | -36.68% | -42.63% | |
Earnings Yield | -825.40% | -23.84% | -10.03% | -22.61% | -15.54% | -30.46% | |
FCF Yield | -19.91% | -58.06% | -13.36% | -14.03% | -27.59% | |
Buyback Yield / Dilution | -12.09% | -37.56% | -6.47% | -34.57% | -100.10% | -33.30% | |
Total Shareholder Return | -12.09% | -37.56% | -6.47% | -34.57% | -100.10% | -33.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.